Attached files

file filename
10-K - 10-K - Inotiv, Inc.tv509358_10k.htm
EX-32.2 - EXHIBIT 32.2 - Inotiv, Inc.tv509358_ex32-2.htm
EX-31.2 - EXHIBIT 31.2 - Inotiv, Inc.tv509358_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Inotiv, Inc.tv509358_ex31-1.htm
EX-23.1 - EXHIBIT 23.1 - Inotiv, Inc.tv509358_ex23-1.htm
EX-21.1 - EXHIBIT 21.1 - Inotiv, Inc.tv509358_ex21-1.htm
EX-10.19 - EXHIBIT 10.19 - Inotiv, Inc.tv509358_ex10-19.htm
EX-10.18 - EXHIBIT 10.18 - Inotiv, Inc.tv509358_ex10-18.htm
EX-10.17 - EXHIBIT 10.17 - Inotiv, Inc.tv509358_ex10-17.htm
EX-10.15 - EXHIBIT 10.15 - Inotiv, Inc.tv509358_ex10-15.htm
EX-10.14 - EXHIBIT 10.14 - Inotiv, Inc.tv509358_ex10-14.htm

 

Exhibit 32.1

 

 

Certifications of Acting Principal Executive Officer

 

Pursuant to Section 906

 

Of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

 

The undersigned, the Acting Principal Executive Officer of Bioanalytical Systems Inc. (the “Company”), hereby certifies that, to the best of his knowledge:

 

(a)the Form 10-K Annual Report of the Company for the fiscal year ended September 30, 2018 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(b)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

By:  /s/  Philip A. Downing

Philip A. Downing
Acting Principal Executive Officer
Date:   December 21, 2018